Commentary

BY ROBERT POPOVIAN & WAYNE WINEGARDEN President Joe Biden should take advantage of a bipartisan opportunity to meaningfully reduce patients’ out-of-pocket spending on biopharmaceuticals. Seizing this opportunity requires the president to recognize that the drug cost problem exists because the current system inappropriately shifts too much of its expenditures...

U.S. healthcare spending has reached a new high, according to the latest federal data. The Centers for Medicare and Medicaid Services estimate national health expenditures reached $3.8 trillion in 2019, an increase of 4.6 percent over the previous year. That’s just under 18 percent of...

There's a COVID-19 vaccine currently saving lives all over the world—but not in the U.S. That vaccine, made by British drug company AstraZeneca, proved 100% effective at preventing hospitalizations and deaths in Phase III clinical trials. British regulators authorized it for use nearly two months ago. Since then, millions of people in...

California’s bullet train has become a nearly forgotten source of trouble, eclipsed in the public eye by Covid-19, a gubernatorial recall, and out-migration from the Golden State. But it’s still out there, sucking up time and money, and as empty as it ever was. The California...

President Biden has repeatedly promised to build a fairer economy, one that “works for everyone.” But if his stimulus plan is any indication, the president has a funny definition of fairness. His $1.9 trillion proposal would force working-class Americans to cover health insurance premiums for people...

A group of Californians who've had enough of Gov. Gavin Newsom say they have the 1.5 million signatures needed to force a recall election, and believe they will eventually have 2 million. But, we probably won't know until after the March 17 submission deadline if...